癌症幸存者更好地采用和采用数字后照顾计划所需要的:应用COM-B模型的混合方法研究
Liza van Deursen1,2, Rosalie van der Vaart3,4, Niels H Chavannes5,6
1Department of National Health and Health Care, Center for Public Health, Health Care and Society, National Institute for Public Health and the Environment, Antonie Van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands. liza.van.deursen@rivm.nl.
概括
癌症幸存者对数字后期护理开放,但不知道它的好处和可用性. 提高认识,澄清价值,解决退款问题是增加这些支持性数字健康工具的关键.
科学领域:
- 数字健康数字健康
- 癌症的生存率 癌症的生存率
- 行为科学 行为科学
背景情况:
- 癌症幸存者经历了多方面的挑战,影响了他们的生活质量.
- 现有的护理服务往往无法满足所有幸存者的需求.
- 数字后期护理计划显示出潜力,但面临着有限的吸收.
研究的目的:
- 确定影响癌症幸存者的数字后照顾计划的吸收和采用因素.
- 探索与癌症幸存者在数字后期护理方面的需求相关的社会人口统计和临床变量.
主要方法:
- 一种混合方法的方法,结合了定性访谈 (n=14) 和定量问卷 (n=213).
- 以COM-B模型 (能力,机会,动机) 为指导的行为分析.
- 使用框架方法分析的定性数据;使用描述和回归统计分析的定量数据.
主要成果:
- 大多数幸存者对数字后期护理的看法都是积极的,他们相信它可以解决与癌症有关的挑战.
- 对于数字化后护计划的认识很低,许多幸存者希望获得更多信息.
- 有关计划有效性和退款的担忧被注意到;社会人口统计学/临床变量没有显著影响需求.
结论:
- 癌症幸存者通常对数字后期护理持好态度,但缺乏对可用的选择的认识.
- 提高认识,展示计划价值,解决支持/退款问题对于改善数字化后期护理的采用至关重要.
- 更多地参与数字后期护理可以促进癌症幸存者的健康,福祉和生活质量.
相关概念视频
Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Modeling in Therapy
65
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
65
Methods of Documentation VI: Case Management Model
565
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
565
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


